The xenotropic microRNA gene information for stem cell researches and clinical applications

Yoichi Robertus Fujii

Retroviral Genetics Group, Nagoya City University, Nagoya, Japan.

DOI: 10.4236/scd.2013.31005                

Abstract

MicorRNA (miRNA) is a small noncoding RNA and a miRNA is the gene. The identification of the human miRNA gene and its application have been performed and then it has been proceeding to explain about functioning of miRNAs in miRNA-messenger RNA targeting, profiling of miRNAs for diseases, transduction of the miRNA gene expression, production of human-induced pluripotent stem (iPS) cells by miRNA, embryonic stem (ES) cells and cancer development upon miRNA. The RNA information supplied by the miRNA gene, and the RNA gene information could expand to intracellular, intercellular, intraorgan, interorgan, intraspecies and interspecies. Therefore, the implantation of ES and iPS cells from donors would deliver xenotropic miRNAs to the acceptor. The therapeutic efficacy for treatment of iPS-derived cell implantation is the most important for clinical development of the stem cell researches but the xenotropic miRNA gene assessment with iPS-derived cells should substantially be completed for a safe and an exact application of the stem cell researches.

Keywords

ES Cell; Evolution; iPS Cells; Implantation; MicroRNA; Retroelement; RNA Wave; Xentropism

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Fujii, Y.R. (2010) RNA genes: Retroelements and virally retroposable microRNAs in human embryonic stem cells. The Open Virology Journal, 4, 63-75. doi:10.2174/1874357901004010063
[2]	Lin, S.L. and Ying, S.Y. (2013) Gene silencing in vitro and in vivo using intronic microRNAs. Methods in Molecular Biology, 936, 209-229.
[3]	Khraiwesh, B., Arif, M.A., Seumel, G.I., Ossowski, S., Weigel, D., Reski, R. and Frank, W. (2009) Transcriptional control of gene expression by microRNAs. Cell, 140, 111-122. doi:10.1016/j.cell.2009.12.023
[4]	Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Benhwich, Z. and Oren, M. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell, 26, 731-743. doi:10.1016/j.molcel.2007.05.017
[5]	Lin, S.-L. and Ying, S.-Y. (2013) Mechanism and Method for generating tumor-free iPS cells using intronic micro RNA miR-302 induction. In: Ying, S.-Y., Ed., MicroRNA Protocols. 2nd Edition, Humana Press, Springer, New York, 295-312.
[6]	Sharma, A. and Wu, J.C. (2013) MicroRNA expression profiling of human-induced pluripotent and embryonic stew cells. In: Ying, S.-Y., Ed., MicroRNA Protocols. 2nd Edition, Humana Press, Springer, New York, 247-256. doi:10.1007/978-1-62703-083-0_19
[7]	Wang, J. and Yang, X. (2012) The function of miRNA in cardiac hypertrophy. Cellular Molecular Life Science, 69, 3561-3570. doi:10.1007/s00018-012-1126-y
[8]	Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L.E. and Galas, D.J. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences, 106, 4402-4407. doi:10.1073/pnas.0813371106
[9]	Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Research, 39, 7223-7233. doi:10.1093/nar/gkr254
[10]	Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D. and Remaley, A.T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology, 13, 423-435. doi:10.1038/ncb2210
[11]	Gibbings, D.J., Ciaudo, C., Erhardt, M. and Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nature Cell Biology, 11, 1143-1151.
[12]	Wang, X., Tang, S., Le, S.Y., Lu, R., Rader, J.S., Meyer, C. and Zheng, Z.-M. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557.
[13]	Wang, X., Wang, H.-K., Mccoy, J.P., Banerjee, N.S., Rader, J.S., Broker, T.R., Meyers, C., Chow, L.T. and Zheng, Z.-M. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA, 15, 637-647. doi:10.1261/rna.1442309
[14]	Meckes Jr., D.G., Shair, K.H.Y., Marquitz, A.R., Kung, C.-P., Edwards, R.H. and Raab-Traub, N. (2010) Human tumor virus utilizes exosomes for intercellular communication. Proceedings of the National Academy of Sciences, 107, 20370-20375. doi:10.1073/pnas.1014194107
[15]	Fujii, Y.R. (2008) Fromulation of new algorithmics for mi RNAs. The Open Virology Journal, 2, 37-43. doi:10.2174/1874357900802010037
[16]	Astolfi, P.A., Salamini, F. and Sgaramella, V. (2010) Are we genomic mosaics? Variations of the genome of somatic cells can contribute to diversity our phenotypes. Current Genomics, 11, 379-386. doi:10.2174/138920210793175949
[17]	Wissing, S., Muo?z-Lopez, M., Macia, A., Yang, Z., Montano, M., Collins, W., Garcia-Perez, J.L., Moran, J.V. and Greene. W.C. (2012) Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Human Molecular Genetics, 21, 208-218. doi:10.1093/hmg/ddr455
[18]	Lin, S.L., Chang, D.C., Chang-Lin, S., Lin, C.H., Wu, D.T., Chen, D.T. and Ying, S.Y. (2008) Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA, 14, 2115-2124. doi:10.1261/rna.1162708
[19]	Anokye-Danso, F., Trivedi, C.M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., Zhang, Y. Yang, W., Gruber, P.J., Epstein, J.A. and Morrisey, E.E. (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8, 376-388. doi:10.1016/j.stem.2011.03.001
[20]	Wang, J. and Yang, X. (2012) The function of miRNA in cardiac hypertrophy. Cellular Molecular Life Sciences, 69, 3561-3570. doi:10.1007/s00018-012-1126-y
[21]	Macfarlan, T.S., Gifford, W.D., Driscoll, S., Lettier, K., Rowe, H.M., Bonanomi, D., Firth, A., Singer, O., Trono, D. and Pfaff, S.L. (2012) Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature, 487, 57-65. doi:10.1038/nature11244
[22]	Séralini, G.E., Clair, E., Mesnage, R., Gress, S., Defarge, N., Malatesta, M., Hennequin, D. and de Vend?mois, J.S. (2012) Long term toxicity of a roundup herbicide and a roundup-tolerant generally modified maize. Food Chemical Toxicology, 50, 4221-4231. doi:10.1016/j.fct.2012.08.005
[23]	Chrupek, M., Siipi, H. and Martinelli, L. (2012) Bio-objects as “boundary crawlers”: The case of microRNA. Croat Medical Journal, 53, 285-288. doi:10.3325/cmj.2012.53.285
[24]	Jiang, M., Sang, X. and Horg, Z. (2012) Beyond nutrients: Food-derived microRNAs provide cross-kingdom regulation. Bioassays, 34, 280-284. doi:10.1002/bies.201100181
[25]	Zhang, L., Hou, D., Chen, X., Donghai, L., Zhu, L., Zhang, L., Li, J., Bian, Z., Liang, X., Cai, X., Yin, Y., Wang, C., Zhang, T., Zhu, D., Zhang, D., Xu, J., Chen, Q., Ba, Y., Liu, J., Wang, Q., Chen, J., Wang, J. Wang, M., Zhang, Q., Zhang, J., Zen, K. and Zhang, C.-Y. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Research, 22, 207-126. doi:10.1038/cr.2011.158
[26]	Garinot, M., Fievenz, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jerome, C., Marchand-Brynaert, J., Schneider, Y.J. and Préat, V. (2007) PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. Journal of Controlled Release, 120, 195-204. doi:10.1016/j.jconrel.2007.04.021
[27]	Sureban, S.M., May, R., Mondalek, F.G., Qu, D., Ponnurangam, S., Pantazis, P., Anant, S., Ramanujam, R.P. and Houchen, C.W. (2011) Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. Journal of Nanobiotechnology, 9, 40. doi:10.1186/1477-3155-9-40
[28]	Fujii, Y.R. (2009) Oncoviruses and pathogenic micro-RNAs in humans. The Open Virology Journal, 3, 37-51.